Buy a Healthcare Business in Switzerland

Switzerland's healthcare system is consistently ranked among the best in the world, underpinned by mandatory health insurance (KVG/LAMal), high per-capita spending of over CHF 9,000 annually, and a rapidly aging population that drives sustained demand. The regulated nature of the market creates predictable revenue streams, making healthcare businesses among the most resilient acquisition targets in Switzerland.

Types of Healthcare Businesses for Sale

• Medical practices (Arztpraxis): General practitioners and specialist practices. Many are available due to retirement, with established patient bases of 1,000–5,000+ patients.
• Dental practices: High-margin businesses with strong private-pay components. Swiss dental care is largely out-of-pocket, creating premium pricing opportunities.
• Pharmacies (Apotheke): Regulated market with cantonal-level concessions. Consolidation trends create acquisition opportunities, particularly for multi-location operators.
• MedTech companies: Switzerland is Europe's leading MedTech hub with over 1,400 companies. Acquisition targets range from device manufacturers to digital health startups.
• Elderly care facilities (Altersheim): Growing demand driven by demographics. Both private and semi-public models exist, with Spitex (home care) services growing rapidly.

Regulatory Considerations

Healthcare acquisitions in Switzerland require careful navigation of cantonal health regulations, Swissmedic requirements for MedTech, professional licensing requirements (FMH for physicians), and compliance with the Federal Act on Data Protection for patient records. Some cantons have specific rules about ownership of medical practices by non-physicians. Pharmacy acquisitions require cantonal pharmacy concessions that may have capacity limits.

Valuation Multiples

Swiss healthcare businesses typically trade at 5–10x EBITDA. Medical practices with strong patient retention and diversified revenue trade at 5–7x, while specialized clinics and MedTech companies with proprietary products can reach 8–10x or higher. Pharmacies generally trade at 4–7x EBITDA depending on location and prescription volume. Recurring revenue from insurance-covered services is valued at a premium due to its predictability.

Why Healthcare Is a Strong Acquisition Target

Demographic tailwinds, mandatory insurance coverage, high barriers to entry, and recession resilience make Swiss healthcare businesses exceptionally stable investments. The aging baby boomer generation of healthcare practitioners also creates a wave of succession opportunities over the next decade, with an estimated 40% of independent medical practices expected to change ownership by 2035.